ММВБ 2 194 0,3%  Nasdaq 12 965 0,2%  Биткойн 22 776 -1,9%  USD/RUB 60,0000 0,0% 
РТС 1 162 2,3%  S&P500 4 284 0,2%  Нефть 96,3 -0,3%  EUR/RUB 60,5070 0,0% 
Dow 33 999 0,1%  FTSE100 7 542 0,4%  Золото 1 756 -0,2%  EUR/USD 1,0085 0,0% 

Pfizer Inc. - Профиль

Pfizer Inc. (Pfizer) – глобальная биофармацевтическая компания. Изобретатель и производителем всемирно известного препарата «Виагра». В 2012 году продажи компании упали на 8% до $57,9 млрд, что было связано с появлением дженериков для ряда ее препаратов, в том числе препарата для снижения уровня холестерина в крови «Липитор». Это одно из наиболее продаваемых лекарств в США и мире. В 2012 году продажи «Липитора» компании Pfizer упали на 60%. Выручка от реализации «Виагры» (6-е место среди наиболее продаваемых препаратов компании) выросла на 4%, до $2,1 млрд.

Акционеры

Название Доля (%)
Freefloat99,98
SSgA Funds Management, Inc.4,99

Адрес

235 East 42nd Street, 10017-5755 New York
а/я:
Телефон: +1 (212) 733-2323
Факс:
Вэб: http://www.pfizer.com

Менеджмент

Albert Bourla
Chairman, Chief Executive & Operating Officer
Aamir Malik
Chief Business Innovation Officer & Executive VP
Sally Susman
Chief Corporate Affairs Officer & Executive VP
William Pao
Chief Development Officer & Executive VP
Brenda Cooperstone
Chief Development Officer & Senior Vice President
David M. Denton
Chief Financial Officer & Executive Vice President
Mike McDermott
Chief Global Supply Officer & Executive VP
Payal Sahni Becher
Chief Human Resources Officer & Executive VP
Aida Habtezion
Chief Medical Officer
Mikael Dolsten
Chief Scientific Officer & Research President
Donna Wartski
Dir-Med Outcomes Specialist, US Medical Affairs
Susan D. Desmond-Hellmann
Director
Denis Patrick
Executive Director
Maritza C. McIntyre
Executive Director-Gene Therapy Product Lead
Rady A. Johnson
Executive VP, Chief Compliance & Risk Officer
Lidia L. Fonseca
Executive VP, Chief Digital & Technology Officer
Douglas M. Lankler
Executive Vice President & General Counsel
Suneet Varma
Global President-Rare Diseases
Angela Hwang
Group President-Biopharmaceuticals
David DeMicco
Head-Medical Affairs, Global Innovative Products
Dan R. Littman
Independent Director
Susan J. Hockfield
Independent Director
Ronald E. Blaylock
Independent Director
Joseph J. Echevarria
Independent Director
James C. Smith
Independent Director
James Quincey
Independent Director
Suzanne Nora Johnson
Independent Director
Helen H. Hobbs
Independent Director
Bryan Dunn
Investor Relations Contact
Shantanu Narayen
Lead Independent Director
Scott Gottlieb
Member of the Board of Directors
Andy Schmeltz
President-US Oncology Business Unit
Margaret M. Madden
Secretary, Chief Governance Counsel & Senior VP
Jennifer B. Damico
Senior VP-Controller & Accounting Officer
Deborah Baron
Senior VP-Worldwide Business Development
Christopher J. Stevo
Senior Vice President
Gordon Loh
Senior Vice President-Corporate Audit
Annaliesa Anderson
VP, Head-Vaccine Research & Development
Markus Green
Vice President & Assistant General Counsel
Hakan Sakul
Vice President & Head-Diagnostics
Eva Grut-Aandahl
Vice President, Head of EU Government Affairs
Barbara J. Dalton
Vice President-Worldwide Business Development
John DeYoung
Vice President-Worldwide Business Development

Добавить или редактировать инструмент